unknown by Konstantinos Fountoulakis et al.
BioMed Central
Page 1 of 1
(page number not for citation purposes)
Annals of General Psychiatry
Open AccessPoster presentation
Long term lithium therapy: a neuroprotective or neurotoxic factor? 
A systematic review of existing data
Konstantinos Fountoulakis*1,2, Eduard Vieta3, Constantin Bouras2, 
Grigorios Notaridis2, Panteleimon Giannakopoulos2 and George Kaprinis1
Address: 13rd Department of Psychiatry, Aristotle University of Thessaloniki, Greece, 2Department of Psychiatry, University of Geneva, Switzerland 
and 3Mood Disorders Clinic, Barcelona, Spain
* Corresponding author    
Background
Lithium is an effective medication for the treatment of
bipolar disorder, but it is unclear whether its long-term
use may result in protective or in toxic consequences.
Materials and methods
The MEDLINE was searched with the combination of the
word: 'Lithium' with key words that referred to every pos-
sible effect on the central nervous system. The papers were
classified into those supporting a neuroprotective effect,
those in favor of a neurotoxic effect and those neutral. The
papers were classified in research in humans, animal and
in vitro research, case reports, and review/opinion articles.
Results
The MEDLINE search returned 913 papers. This number
concerns February 2005. The scanning of the abstracts
selected 238 papers for further reviewing.
95 papers supported the neuroprotective effect (6 human
research, 63 animal/in vitro, 0 case reports, 26 reviews/
opinion articles).
135 papers supported the neurotoxic effect (18 human
research, 21 animal/in vitro, 74 case reports, 22 reviews/
opinion articles).
8 papers supported no hypothesis (5 human research, 2
animal/in vitro, 0 case reports, 1 reviews/opinion arti-
cles).
Discussion
Although more papers are in favor of the neurotoxic effect,
the great difference in the type of papers that support
either hypothesis, along with publication bias and meth-
odological issues make conclusions difficult. It seems that
there is a possibility of a toxic effect in real-life clinical
practice even in well-followed patients.
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